Important Clarification & Product Assessment (English):
The product name "DIAMPA M5+1000mg Tablets" may suggest a dapagliflozin-based combination due to the "DIAMPA" brand. However, this is not a dapagliflozin product.
Here’s why:
- ✅ Dapagliflozin is only approved in 5mg and 10mg doses.
- ❌ Dapagliflozin is never combined with metformin under a label like "M5+1000" in standard DIAMPA formulations.
- In Pakistan, the notation "M5+1000" in antidiabetic brands typically refers to Glimepiride + Metformin, where "M5" is a local marketing code—not the actual dose of glimepiride.
🔍 Conclusion:
Despite the "DIAMPA" name, this product almost certainly contains Glimepiride 2mg + Metformin 1000mg, a widely used dual-combination therapy for type 2 diabetes in Pakistan.
⚠️ Dapagliflozin is NOT present in this formulation.
Confirmed Likely Composition:
✅ Active Ingredients:
- Glimepiride 2mg
- Metformin Hydrochloride 1000mg
This is a standard, high-strength dual therapy for patients requiring intensified glycemic control.
Product Full Description (English):
Uses:
- Management of type 2 diabetes mellitus in adults inadequately controlled on monotherapy or lifestyle measures
- Simplified dual therapy to improve adherence and reduce pill burden
Key Benefits:
- Glimepiride: Stimulates insulin secretion from pancreatic beta cells
- Metformin: Reduces hepatic glucose production and improves insulin sensitivity
- High metformin dose (1000mg) provides robust glucose-lowering effect
- Once- or twice-daily dosing flexibility
How To Use:
Take once or twice daily with meals (usually breakfast and/or dinner) to reduce hypoglycemia risk. Swallow whole with water—do not crush or chew.
When Not to Use:
- Type 1 diabetes or diabetic ketoacidosis
- Severe renal impairment (eGFR <30 mL/min)
- Hypersensitivity to sulfonylureas or metformin
- Acute alcohol intoxication, liver disease, or metabolic acidosis
Side Effects:
- Common: Hypoglycemia (sweating, tremor, dizziness, confusion), nausea, diarrhea, metallic taste
- Serious (rare): Lactic acidosis (muscle pain, weakness, rapid breathing), severe hypoglycemia, liver enzyme elevation
Dosage:
- Typical dose: 1 tablet once or twice daily with meals
- Maximum glimepiride: usually 4–6mg/day (i.e., up to 2–3 tablets)
- Adjust based on blood glucose and HbA1c monitoring
Warnings & Precautions:
- Hypoglycemia risk increases with skipped meals, intense exercise, or alcohol
- Avoid alcohol—raises risk of lactic acidosis and low blood sugar
- Discontinue before iodinated contrast imaging or major surgery
- Monitor kidney function and HbA1c regularly
Drug Interactions:
- Alcohol: ↑ Risk of lactic acidosis and hypoglycemia
- Beta-blockers: May mask hypoglycemia symptoms (e.g., palpitations)
- NSAIDs, sulfonamides, warfarin: May potentiate glimepiride → hypoglycemia
- Cimetidine: May increase metformin levels
Critical Recommendation:
🔍 Always verify the active ingredients printed on the packaging.
- If it lists "Glimepiride 2mg + Metformin 1000mg", this description applies.
- If it claims "Dapagliflozin 5mg + Metformin 1000mg", it is non-standard—consult your pharmacist immediately.
In Pakistan,